This new research provides key data, information and
analysis on the global electrosurgical devices market. The report provides
market landscape, competitive landscape and market trends information on the
electrosurgical devices market. The report provides comprehensive information
on the key trends affecting the market, and key analytical content on the
market dynamics. The report also reviews the competitive landscape and
technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Electrosurgical Market Scope:
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Electrosurgical Market Scope:
·
Key geographies covered include the US, Canada, the
UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
·
Key segments covered include Electrosurgical
Disposables and Accessories and Electrosurgical Generators.
·
Annualized market revenues data from 2004 to 2011,
forecast forward for seven years to 2018. Company shares data for 2011.
·
Qualitative analysis of key market trends, market
drivers, and restraints by each segment within electrosurgical devices market.
·
The report also covers information on the leading
market players, the competitive landscape, and the leading pipeline products
and technologies.
·
Key players covered include Covidien, Erbe
Elektromedizin, ConMed Corporation, Bovie Medical Corporation, Codman &
Shurtleff, KLS Martin Group and B. Braun Melsungen.
Reasons to Buy
·
Develop business strategies by understanding the
trends and developments that are driving the electrosurgical devices globally.
·
Design and develop your product development,
marketing and sales strategies.
·
Develop market-entry and market expansion
strategies.
·
Identify key players best positioned to take
advantage of the emerging market opportunities.
·
Exploit in-licensing and out-licensing opportunities
by identifying products that are most likely to ensure a robust return.
·
What's the next big thing in the electrosurgical devices market landscape? - Identify, understand and capitalize.
·
Make more informed business decisions from the
insightful and in-depth analysis of the global electrosurgical devices market
and the factors shaping it.
More
Information:
Global
Electrosurgical Devices Market to Grow at a CAGR of 5% from 2011-2018
The global electrosurgical devices market is expected to grow at a CAGR of 5% to $1,412.8m by 2018. The market is expected to be driven by the growing demand for minimally invasive procedures and technology advances that make surgery safer and less destructive to the surrounding tissue.
Covidien, Erbe and ConMed Lead the Global Electrosurgical Devices Market
The global electrosurgical devices market is dominated by three companies – Covidien, Erbe and ConMed. Covidien is the market leader with nearly 40% market share. Erbe is the second largest market player with an 11% market share. Erbe has a strong presence in European countries such as Germany. The company also has a significant presence in the US electrosurgical devices market. ConMed is the third largest market player with an 8% market share. ConMed displays strong presence in both the US and Asia-Pacific markets. Other significant market players include Bovie, KLS Martin, B. Braun and Bowa. However, all of these companies have less than 5% market shares in the global market.
Technology Advances Addressing Problems Such as Collateral Tissue Damage and Eschar are Enhancing the Performance of Electrosurgery and Leading to Greater Adoption
New technologies protect tissue surfaces from thermal damage, as well as reduce eschar formation and limit tissue sticking.. Sticking and charring is undesirable since it can result in unintentional damage to delicate tissue. Eschar on electrodes increases the impedance and presents a fire hazard. It also results in longer surgery time since the tools need to be constantly removed and cleaned of the charred tissue. Examples include Isocool Tips by Codman and PlasmaBlade technology by Peak Surgicals.
In-built features in the electrosurgical generators allow surgeons to closely monitor tissue impedance and adjust the voltage accordingly. The innovative design of cutting and coagulation accessories also helps to control the temperature of the tissue and prevent charring and sticking. These are expected to drive their adoption among surgeons.
Growing Number of Procedures Performed at the Doctor’s Office to Drive the Sales of Electrosurgical Generators Designed Specifically for Outpatient Surgeries
Multiple procedures, such as loop electrosurgical excision procedures (LEEP) and the removal of superficial skin lesions, tags, warts and cysts, are now routinely performed as outpatient procedures. In recent years, there has been a significant increase in the number of outpatient procedures compared to inpatient procedures. The reason for this is that outpatient procedures can be performed at a much lower cost than inpatient procedures. Inpatient procedures are inherently costlier since they require the patient to spend some days at the hospital. In contrast, most outpatient surgeries are performed during the day with the patient able to leave at the end of the day. Thus, they offer patients greater convenience in terms of location, the ability to schedule surgery quickly, and shorter waiting times.
The global electrosurgical devices market is expected to grow at a CAGR of 5% to $1,412.8m by 2018. The market is expected to be driven by the growing demand for minimally invasive procedures and technology advances that make surgery safer and less destructive to the surrounding tissue.
Covidien, Erbe and ConMed Lead the Global Electrosurgical Devices Market
The global electrosurgical devices market is dominated by three companies – Covidien, Erbe and ConMed. Covidien is the market leader with nearly 40% market share. Erbe is the second largest market player with an 11% market share. Erbe has a strong presence in European countries such as Germany. The company also has a significant presence in the US electrosurgical devices market. ConMed is the third largest market player with an 8% market share. ConMed displays strong presence in both the US and Asia-Pacific markets. Other significant market players include Bovie, KLS Martin, B. Braun and Bowa. However, all of these companies have less than 5% market shares in the global market.
Technology Advances Addressing Problems Such as Collateral Tissue Damage and Eschar are Enhancing the Performance of Electrosurgery and Leading to Greater Adoption
New technologies protect tissue surfaces from thermal damage, as well as reduce eschar formation and limit tissue sticking.. Sticking and charring is undesirable since it can result in unintentional damage to delicate tissue. Eschar on electrodes increases the impedance and presents a fire hazard. It also results in longer surgery time since the tools need to be constantly removed and cleaned of the charred tissue. Examples include Isocool Tips by Codman and PlasmaBlade technology by Peak Surgicals.
In-built features in the electrosurgical generators allow surgeons to closely monitor tissue impedance and adjust the voltage accordingly. The innovative design of cutting and coagulation accessories also helps to control the temperature of the tissue and prevent charring and sticking. These are expected to drive their adoption among surgeons.
Growing Number of Procedures Performed at the Doctor’s Office to Drive the Sales of Electrosurgical Generators Designed Specifically for Outpatient Surgeries
Multiple procedures, such as loop electrosurgical excision procedures (LEEP) and the removal of superficial skin lesions, tags, warts and cysts, are now routinely performed as outpatient procedures. In recent years, there has been a significant increase in the number of outpatient procedures compared to inpatient procedures. The reason for this is that outpatient procedures can be performed at a much lower cost than inpatient procedures. Inpatient procedures are inherently costlier since they require the patient to spend some days at the hospital. In contrast, most outpatient surgeries are performed during the day with the patient able to leave at the end of the day. Thus, they offer patients greater convenience in terms of location, the ability to schedule surgery quickly, and shorter waiting times.
Buy your copy of this report @ http://www.rnrmarketresearch.com/electrosurgical-devices-market-global-pipeline-analysis-competitive-landscape-and-market-forecasts-to-2018-market-report.html
Report
Details:
Published: Feb 2012
No Of
Pages: 65
Price: Single User License: US$ 3995 Corporate User License: US$ 11985
No comments:
Post a Comment